Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 22,175 | 16,851 | 9,413 | 8,553 | 9,387 |
| Cost of Goods | 18,892 | 14,720 | 8,031 | 7,360 | 7,683 |
| Gross Profit | 3,282 | 2,131 | 1,381 | 1,193 | 1,704 |
| Operating Expenses | 935 | 742 | 527 | 538 | 556 |
| Operating Income | 2,347 | 1,390 | 855 | 654 | 1,148 |
| Other Income | 297 | -504 | -196 | 460 | 31 |
| Pre-tax Income | 2,644 | 886 | 659 | 1,114 | 1,179 |
| Income Tax | 1,002 | 328 | 362 | 297 | 387 |
| Net Income Continuous | 1,643 | 558 | 297 | 817 | 792 |
| Net Income | $1,643 | $558 | $297 | $817 | $792 |
| EPS Basic Total Ops | 0.09 | 0.03 | 0.02 | 0.04 | 0.04 |
| EPS Basic Continuous Ops | 0.09 | 0.03 | 0.02 | 0.04 | 0.04 |
| EPS Diluted Total Ops | 0.09 | 0.03 | 0.02 | 0.04 | 0.04 |
| EPS Diluted Continuous Ops | 0.09 | 0.03 | 0.02 | 0.04 | 0.04 |
| EBITDA(a) | $3,349 | $2,131 | $1,381 | $1,193 | $1,732 |